Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4476053 | 0.98 | SHBG (0.40) | SHBGEPHX1ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL4463799 | 0.86 | SHBG (0.45) | SHBGEPHX1ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL14088062 | 0.85 | SHBG (0.43) | SHBGEPHX1ALDH1A1TSHRLMNA | |
| SCHEMBL2380868 | 0.85 | SHBG (0.43) | SHBGEPHX1ALDH1A1TSHRLMNA | |
| SCHEMBL4476043 | 0.84 | SHBG (0.41) | SHBGEPHX1ALDH1A1TSHRNPSR1 | |
| SCHEMBL29094051 | 0.83 | SHBG (0.42) | SHBGEPHX1ALDH1A1TSHRNPSR1 | |
| SCHEMBL10657782 | 0.83 | SHBG (0.42) | SHBGEPHX1ALDH1A1CYP2C9CYP2C19 | |
| Procymate SCHEMBL1651001 | 0.83 | EPHX1 (0.44) | SHBGEPHX1ALDH1A1TP53 | |
| SCHEMBL28943266 | 0.81 | ALDH1A1 (0.40) | SHBGEPHX1ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL3469911 | 0.81 | ALDH1A1 (0.38) | EPHX1ALDH1A1CYP2C9CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7625943-B2 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J | 2009-12-01 | — | — | US | claimed |
| US-20050113354-A1 | Bioavailable prodrugs of androgenic steroids and related method | ROBERTS WILLIAM J (US) | 2005-05-26 | — | — | US | claimed |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J (US) | 2005-03-24 | — | — | US | claimed |
| US-6818668-B2 | ADMINISTERING PRODRUGS OF METABOLITES SUCH AS 5-METHYL-7-ETHYL CARBONATE-ISOFLAVONE, TO INCREASING CONCENTRATION OF FLAVONOIDS | BIOTEST LABORATORIES, LLC | 2004-11-16 | — | — | US | claimed |
| US-6740646-B2 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2004-05-25 | — | — | US | claimed |
| WO-2003087083-A1 | 5-ALKYL-7-ALKYLCARBONATE-ISOFLAVONE ESTER AS ISOFLAVONE PRODRUG | BIOTEST LABORATORIES, LLC (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | BIOTEST LABORATORIES, LLC | 2003-10-16 | — | — | US | claimed |
| US-20030134830-A1 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2003-07-17 | — | — | US | claimed |
| US-7625943-B2 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J | 2009-12-01 | — | — | US | disclosed |
| US-20050113354-A1 | Bioavailable prodrugs of androgenic steroids and related method | ROBERTS WILLIAM J (US) | 2005-05-26 | — | — | US | disclosed |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J (US) | 2005-03-24 | — | — | US | disclosed |
| US-6818668-B2 | ADMINISTERING PRODRUGS OF METABOLITES SUCH AS 5-METHYL-7-ETHYL CARBONATE-ISOFLAVONE, TO INCREASING CONCENTRATION OF FLAVONOIDS | BIOTEST LABORATORIES, LLC | 2004-11-16 | — | — | US | disclosed |
| US-6740646-B2 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2004-05-25 | — | — | US | disclosed |
| WO-2003087083-A1 | 5-ALKYL-7-ALKYLCARBONATE-ISOFLAVONE ESTER AS ISOFLAVONE PRODRUG | BIOTEST LABORATORIES, LLC (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | BIOTEST LABORATORIES, LLC | 2003-10-16 | — | — | US | disclosed |
| US-20030134830-A1 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2003-07-17 | — | — | US | disclosed |
| US-20030134828-A1 | Composition and method for increasing in vivo androgen concentration | ROBERTS WILLIAM J (US) | 2003-07-17 | — | — | US | disclosed |
| US-20030134831-A1 | Bioavailable prodrugs of androgenic steroids and related method | BIOTEST LABORATORIES, LLC | 2003-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | SHBG 41/4885EPHX1 1230/4885ALDH1A1 708/4885 |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | SHBG 42/4885EPHX1 1245/4885ALDH1A1 696/4885 |
| US-20030134828-A1 | Composition and method for increasing in vivo androgen concentration | SHBG, CYP21A2, CYP19A1 | SHBG 1/4885EPHX1 1639/4885ALDH1A1 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.